Chief Executive Officer
In times of crisis, it is good to have a partner like Oost NL. Where possible they show financial leniency and they bring proactive other support options to our attention.
78% mortality reduction in ICU-admitted COVID-19 patients in Suriname after treatment with convalescent plasma (CP) obtained by the HemoClear blood filter.
HemoClear B.V. received CE Mark approval for its first-in-class, technology, the HemoClearTM autologous blood filter
As a proud sponsor, HemoClear is attending the 28th Nigerian Society of Anaesthetists Annual Scientific Conference. Dr Rosita Bihariesingh has been at the